Related Experiment Video
Updated: Dec 26, 2025

Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
Effects of Internal Exposure to 56MnO2 Powder on Blood Parameters in Rats
Nariaki Fujimoto1, Arailym Baurzhan2, Nailya Chaizhunusova2
1Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Objective:
The pathological effects of internal exposure to manganese dioxide-56 (56MnO2) radioisotope particles have been previously examined in rats. Here we further examine the effects of 56MnO2, focusing on changes in blood parameters.
Materials And Methods:
Ten-week-old male Wistar rats were exposed to 3 doses of neutron-activated 56MnO2 powder, nonradioactive MnO2 powder, or external 60Co γ-rays (1 Gy, whole body). On days 3 and 61 postexposure, the animals were necropsied to measure organ weights and clinical blood parameters, including red blood cell and white blood cell counts; concentrations of calcium, phosphorus, potassium, and sodium; and levels of alanine aminotransferase (ALT), aspartate aminotransferase, amylase, creatinine, urea, total protein, albumin, triglycerides, high density lipoprotein, total cholesterol, and glucose.
Results:
In the 56MnO2-exposed animals, accumulated doses were found to be highest in the gastrointestinal tract, followed by the skin and lungs, with whole-body doses ranging from 41 to 100 mGy. There were no 56MnO2 exposure-related changes in body weights or relative organ weights. The ALT level decreased on day 3 and then significantly increased on day 61 in the 56MnO2-exposed groups. There were no exposure-related changes in any other blood parameters.
Conclusion:
Although the internal doses were less than 100 mGy, internal exposure of 56MnO2 powder showed significant biological impacts.
Insights
Internal manganese dioxide-56 (56MnO2) radioisotope exposure in rats caused significant biological impacts, notably altering alanine aminotransferase (ALT) levels. These findings highlight the potential health risks of radioactive manganese dioxide particle exposure.
Area of Science:
- Radiobiology
- Toxicology
- Biochemistry
Background:
- Previous studies investigated the pathological effects of internal manganese dioxide-56 (56MnO2) radioisotope particle exposure in rats.
- This study focuses on the specific impact of 56MnO2 on blood parameters in rats.
Purpose of the Study:
- To investigate the effects of internal exposure to manganese dioxide-56 (56MnO2) radioisotope particles on blood parameters in rats.
- To assess changes in clinical blood parameters following exposure to varying doses of 56MnO2.
Main Methods:
- Ten-week-old male Wistar rats were exposed to three doses of neutron-activated 56MnO2 powder, nonradioactive MnO2 powder, or external 60Co γ-rays.
- Organ weights and clinical blood parameters were measured on days 3 and 61 postexposure.
- Blood parameters analyzed included cell counts, electrolyte concentrations, and levels of various enzymes and metabolites.
Main Results:
- 56MnO2 exposure resulted in accumulated doses primarily in the gastrointestinal tract, skin, and lungs, with whole-body doses ranging from 41 to 100 mGy.
- No significant changes were observed in body weights or relative organ weights.
- Alanine aminotransferase (ALT) levels decreased on day 3 and significantly increased on day 61 in 56MnO2-exposed groups; other blood parameters showed no exposure-related changes.
Conclusions:
- Internal exposure to 56MnO2 powder demonstrated significant biological impacts, even at accumulated doses below 100 mGy.
- The observed changes in ALT levels suggest a potential for delayed biological effects following 56MnO2 exposure.
- Further research is warranted to fully elucidate the long-term toxicological profile of internal radioactive manganese dioxide exposure.
More Related Videos
08:25Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
09:29An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020